Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy BioSig Technologies stock

Own BioSig Technologies stock in just a few minutes.

BioSig Technologies, Inc is a medical devices business based in the US. BioSig Technologies shares (BSGM) are listed on the NASDAQ and all prices are listed in US Dollars. BioSig Technologies employs 49 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in BioSig Technologies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BSGM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

BioSig Technologies share price

Use our graph to track the performance of BSGM stocks over time.

BioSig Technologies shares at a glance

Information last updated 2021-04-30.
52-week range$2.80 - $12.43
50-day moving average $4.28
200-day moving average $4.44
Wall St. target price$13.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.30

Buy BioSig Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy BioSig Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BioSig Technologies financials

Gross profit TTM $0
Return on assets TTM -165.86%
Return on equity TTM -318.36%
Profit margin 0%
Book value $0.79
Market capitalisation $117 million

TTM: trailing 12 months

Shorting BioSig Technologies shares

There are currently 2.5 million BioSig Technologies shares held short by investors – that's known as BioSig Technologies's "short interest". This figure is 4.5% up from 2.4 million last month.

There are a few different ways that this level of interest in shorting BioSig Technologies shares can be evaluated.

BioSig Technologies's "short interest ratio" (SIR)

BioSig Technologies's "short interest ratio" (SIR) is the quantity of BioSig Technologies shares currently shorted divided by the average quantity of BioSig Technologies shares traded daily (recently around 205224.87520799). BioSig Technologies's SIR currently stands at 12.02. In other words for every 100,000 BioSig Technologies shares traded daily on the market, roughly 12020 shares are currently held short.

However BioSig Technologies's short interest can also be evaluated against the total number of BioSig Technologies shares, or, against the total number of tradable BioSig Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BioSig Technologies's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 BioSig Technologies shares in existence, roughly 80 shares are currently held short) or 0.0876% of the tradable shares (for every 100,000 tradable BioSig Technologies shares, roughly 88 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against BioSig Technologies.

Find out more about how you can short BioSig Technologies stock.

BioSig Technologies share dividends

We're not expecting BioSig Technologies to pay a dividend over the next 12 months.

Have BioSig Technologies's shares ever split?

BioSig Technologies's shares were split on a 2:5 basis on 10 September 2018. So if you had owned 5 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your BioSig Technologies shares – just the quantity. However, indirectly, the new 150% higher share price could have impacted the market appetite for BioSig Technologies shares which in turn could have impacted BioSig Technologies's share price.

BioSig Technologies share price volatility

Over the last 12 months, BioSig Technologies's shares have ranged in value from as little as $2.797 up to $12.43. A popular way to gauge a stock's volatility is its "beta".

BSGM.US volatility(beta: 1.79)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioSig Technologies's is 1.7921. This would suggest that BioSig Technologies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

BioSig Technologies overview

BioSig Technologies, Inc. , together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site